Truist Financial analyst Jailendra Singh maintained a Hold rating on CareMax (CMAX – Research Report) today. The company’s shares closed yesterday at $3.01.
Singh covers the Healthcare sector, focusing on stocks such as IQVIA Holdings, R1 RCM, and Icon. According to TipRanks, Singh has an average return of -14.4% and a 33.33% success rate on recommended stocks.
CareMax has an analyst consensus of Hold, with a price target consensus of $4.70.
Based on CareMax’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $151.84 million and a GAAP net loss of $465.77 million. In comparison, last year the company earned a revenue of $164.26 million and had a net profit of $10.44 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CareMax (CMAX) Company Description:
Deerfield Healthcare Technology Acquisitions Corp is a blank check company.
